Yongwei Hu

Guangzhou, 510630, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Corrigendum to "Self-intensified synergy of a versatile biomimetic nanozyme and doxorubicin on electrospun fibers to inhibit postsurgical tumor recurrence and metastasis" [Biomaterials 293 (2023) 121942].

Corrigendum to "Self-intensified synergy of a versatile biomimetic nanozyme and doxorubicin on electrospun fibers to inhibit postsurgical tumor recurrence and metastasis" [Biomaterials 293 (2023) 121942].

Journal: Biomaterials

Published: August 07, 2026

Low-dose bevacizumab plus atezolizumab enhances transarterial chemoembolization in HCC via correcting vascular-immune niche dysfunction.

Low-dose bevacizumab plus atezolizumab enhances transarterial chemoembolization in HCC via correcting vascular-immune niche dysfunction.

Journal: Journal of hepatology

Published: February 09, 2026

Development and validation of a simplified dynamic nomogram for preoperative prediction of microvascular invasion in hepatocellular carcinoma.

Development and validation of a simplified dynamic nomogram for preoperative prediction of microvascular invasion in hepatocellular carcinoma.

Journal: European journal of gastroenterology & hepatology

Published: November 18, 2025

Low-dose chemotherapy remodels hepatic immune landscape and potentiates anti-tumor response to immune checkpoint blockade in cholangiocarcinoma.

Low-dose chemotherapy remodels hepatic immune landscape and potentiates anti-tumor response to immune checkpoint blockade in cholangiocarcinoma.

Journal: Hepatology (Baltimore, Md.)

Published: November 01, 2025

Immune checkpoint inhibitors in hepatocellular carcinoma therapy: resistance mechanisms, liver transplantation challenges and management strategies.

Immune checkpoint inhibitors in hepatocellular carcinoma therapy: resistance mechanisms, liver transplantation challenges and management strategies.

Journal: Cancer drug resistance (Alhambra, Calif.)

Published: July 18, 2025

Multi-faceted nanodrug reinforcing metalloimmunotherapy for hepatocellular carcinoma.

Multi-faceted nanodrug reinforcing metalloimmunotherapy for hepatocellular carcinoma.

Journal: Biomaterials

Published: June 01, 2025

Research landscape and trends of human umbilical cord mesenchymal stem cell-derived exosomes.

Research landscape and trends of human umbilical cord mesenchymal stem cell-derived exosomes.

Journal: Stem cell research & therapy

Published: February 19, 2025

Drug-loaded indocyanine green J-aggregates activate metalloimmunotherapy for sustained photothermal therapy of hepatocellular carcinoma.

Drug-loaded indocyanine green J-aggregates activate metalloimmunotherapy for sustained photothermal therapy of hepatocellular carcinoma.

Journal: Journal of nanobiotechnology

Published: January 10, 2025

Tissue-resident peripheral helper T cells foster hepatocellular carcinoma immune evasion by promoting regulatory B-cell expansion.

Tissue-resident peripheral helper T cells foster hepatocellular carcinoma immune evasion by promoting regulatory B-cell expansion.

Journal: Chinese medical journal

Published: December 26, 2024

Prediction model for hepatocellular carcinoma recurrence after hepatectomy: Machine learning-based development and interpretation study.

Prediction model for hepatocellular carcinoma recurrence after hepatectomy: Machine learning-based development and interpretation study.

Journal: Heliyon

Published: May 24, 2023

Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8+ exhausted-like T cells.

Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8+ exhausted-like T cells.

Journal: Nature communications

Published: March 31, 2023

Self-intensified synergy of a versatile biomimetic nanozyme and doxorubicin on electrospun fibers to inhibit postsurgical tumor recurrence and metastasis.

Self-intensified synergy of a versatile biomimetic nanozyme and doxorubicin on electrospun fibers to inhibit postsurgical tumor recurrence and metastasis.

Journal: Biomaterials

Published: August 29, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026